MiMedx Group (MDXG) Competitors $7.14 +0.25 (+3.63%) Closing price 09/11/2025 04:00 PM EasternExtended Trading$7.14 0.00 (0.00%) As of 06:44 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock MDXG vs. TMDX, SLNO, NVST, LIVN, INSP, WRBY, LQDA, PRCT, LMAT, and AORTShould you be buying MiMedx Group stock or one of its competitors? The main competitors of MiMedx Group include TransMedics Group (TMDX), Soleno Therapeutics (SLNO), Envista (NVST), LivaNova (LIVN), Inspire Medical Systems (INSP), Warby Parker (WRBY), Liquidia Technologies (LQDA), PROCEPT BioRobotics (PRCT), LeMaitre Vascular (LMAT), and Artivion (AORT). These companies are all part of the "medical equipment" industry. MiMedx Group vs. Its Competitors TransMedics Group Soleno Therapeutics Envista LivaNova Inspire Medical Systems Warby Parker Liquidia Technologies PROCEPT BioRobotics LeMaitre Vascular Artivion TransMedics Group (NASDAQ:TMDX) and MiMedx Group (NASDAQ:MDXG) are both medical companies, but which is the superior business? We will contrast the two companies based on the strength of their earnings, media sentiment, profitability, risk, analyst recommendations, dividends, institutional ownership and valuation. Do institutionals and insiders have more ownership in TMDX or MDXG? 99.7% of TransMedics Group shares are owned by institutional investors. Comparatively, 79.2% of MiMedx Group shares are owned by institutional investors. 7.0% of TransMedics Group shares are owned by insiders. Comparatively, 1.7% of MiMedx Group shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth. Do analysts rate TMDX or MDXG? TransMedics Group presently has a consensus target price of $122.11, indicating a potential upside of 4.38%. MiMedx Group has a consensus target price of $12.00, indicating a potential upside of 68.07%. Given MiMedx Group's stronger consensus rating and higher probable upside, analysts plainly believe MiMedx Group is more favorable than TransMedics Group.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score TransMedics Group 0 Sell rating(s) 4 Hold rating(s) 5 Buy rating(s) 1 Strong Buy rating(s) 2.70MiMedx Group 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Is TMDX or MDXG more profitable? TransMedics Group has a net margin of 13.49% compared to MiMedx Group's net margin of 8.84%. TransMedics Group's return on equity of 28.02% beat MiMedx Group's return on equity.Company Net Margins Return on Equity Return on Assets TransMedics Group13.49% 28.02% 8.64% MiMedx Group 8.84%23.03%17.09% Which has better valuation & earnings, TMDX or MDXG? MiMedx Group has lower revenue, but higher earnings than TransMedics Group. MiMedx Group is trading at a lower price-to-earnings ratio than TransMedics Group, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioTransMedics Group$441.54M9.03$35.46M$1.9360.62MiMedx Group$348.88M3.03$42.42M$0.2134.00 Which has more risk & volatility, TMDX or MDXG? TransMedics Group has a beta of 2.18, meaning that its stock price is 118% more volatile than the S&P 500. Comparatively, MiMedx Group has a beta of 1.74, meaning that its stock price is 74% more volatile than the S&P 500. Does the media refer more to TMDX or MDXG? In the previous week, TransMedics Group had 8 more articles in the media than MiMedx Group. MarketBeat recorded 9 mentions for TransMedics Group and 1 mentions for MiMedx Group. MiMedx Group's average media sentiment score of 1.79 beat TransMedics Group's score of 0.86 indicating that MiMedx Group is being referred to more favorably in the news media. Company Overall Sentiment TransMedics Group Positive MiMedx Group Very Positive SummaryTransMedics Group beats MiMedx Group on 12 of the 17 factors compared between the two stocks. Get MiMedx Group News Delivered to You Automatically Sign up to receive the latest news and ratings for MDXG and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding MDXG and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart MDXG vs. The Competition Export to ExcelMetricMiMedx GroupMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.02B$3.15B$5.78B$10.07BDividend YieldN/A2.32%5.69%4.62%P/E Ratio34.0021.6075.0626.20Price / Sales3.03297.80472.2591.86Price / Cash20.8045.3337.0859.91Price / Book5.459.7112.246.28Net Income$42.42M-$53.33M$3.29B$270.85M7 Day PerformanceN/A1.04%1.56%3.58%1 Month Performance-1.24%9.93%7.88%6.67%1 Year Performance16.10%13.80%63.05%27.73% MiMedx Group Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)MDXGMiMedx Group3.523 of 5 stars$7.14+3.6%$12.00+68.1%+15.3%$1.02B$348.88M34.00870Positive NewsTMDXTransMedics Group2.7517 of 5 stars$114.96-1.5%$123.00+7.0%-18.6%$3.92B$441.54M59.57210SLNOSoleno Therapeutics4.3888 of 5 stars$67.67-1.1%$115.09+70.1%+16.8%$3.60BN/A-16.3530Trending NewsAnalyst UpgradeShort Interest ↑Analyst RevisionNVSTEnvista3.9546 of 5 stars$21.15-0.5%$20.92-1.0%+22.5%$3.52B$2.51B66.0812,300Positive NewsLIVNLivaNova2.8064 of 5 stars$56.37+1.7%$59.71+5.9%+20.8%$3.08B$1.25B-14.492,900Positive NewsINSPInspire Medical Systems4.9127 of 5 stars$93.86+2.6%$165.62+76.4%-60.0%$2.77B$802.80M54.261,246Positive NewsGap UpWRBYWarby Parker1.5906 of 5 stars$26.16-0.3%$24.06-8.0%+96.3%$2.76B$771.32M-373.723,780Positive NewsInsider TradeLQDALiquidia Technologies3.389 of 5 stars$27.68+0.8%$32.11+16.0%+166.0%$2.38B$14M-16.2850Positive NewsPRCTPROCEPT BioRobotics3.2646 of 5 stars$40.17-0.4%$74.88+86.4%-50.5%$2.23B$224.50M-25.92430Positive NewsLMATLeMaitre Vascular2.9972 of 5 stars$95.36+0.1%$97.60+2.3%+8.6%$2.16B$219.86M46.29490Positive NewsAORTArtivion2.7654 of 5 stars$43.87+0.1%$40.63-7.4%+73.7%$2.07B$388.54M-104.451,600Positive News Related Companies and Tools Related Companies TransMedics Group Alternatives Soleno Therapeutics Alternatives Envista Alternatives LivaNova Alternatives Inspire Medical Systems Alternatives Warby Parker Alternatives Liquidia Technologies Alternatives PROCEPT BioRobotics Alternatives LeMaitre Vascular Alternatives Artivion Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:MDXG) was last updated on 9/12/2025 by MarketBeat.com Staff From Our PartnersStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredTrump’s Plan May Undo 1933’s Biggest Financial InjusticeTrump's Reset Can Give Birth To America's Greatest Era Yet A 90-Year cycle may end soon, creating real weal...American Hartford Gold | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredTrump’s new AI budget just passed — one stock could soarIn a quiet move few people noticed... President Trump just green-lit what could become the biggest AI budge...Behind the Markets | SponsoredCollege grad makes $64,000 a monthIt's easy to feel like you've missed out on the biggest stock market boom of the century. But if you want t...Stansberry Research | SponsoredUrgent: $3,452.50 a Month in Passive "AI Equity Checks"The U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding MiMedx Group, Inc Please log in to your account or sign up in order to add this asset to your watchlist. Share MiMedx Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free MDXG Stock Alerts